ClinicalTrials.Veeva

Menu

Aspirin and the Risk of Microscopic Hematuria in Asymptomatic Screened Population

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Microscopic Hematuria
Asymptomatic General Population

Study type

Observational

Funder types

Other

Identifiers

NCT01615315
SNUBH-URO-2012-01

Details and patient eligibility

About

Aspirin can increase the risk of bleeding tendency. However, correlation between aspirin treatment and hematuria in general population is not well known. The investigators will evaluate whether daily use of aspirin increase the risk of microscopic hematuria in healthy large screened populations.

Enrollment

60,048 patients

Sex

All

Ages

20 to 89 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 20 years, male or female

Exclusion criteria

  • No result of urinalysis
  • No record of medical history (including medication)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems